| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5691992 | Urology | 2016 | 26 Pages |
Abstract
The existing literature on pathologic risk factors for OMD in this population is insufficient to make broad clinical recommendations. However, these factors appear to risk-stratify patients and may be useful for future research investigating adjuvant therapy in higher-risk patients. This review indicates that such a stratification system has a rational basis.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kyle O. Rove, Paul D. Maroni, Carrye R. Cost, Diane L. Fairclough, Gianluca Giannarini, Anne K. Harris, Kris Ann P. Schultz, Nicholas G. Cost,